Sensitivity analysis assessing the impact of the 2013 ESH/ESC Guidelines on costs, proportion of benefits and efficiency.

Abbreviations: n, number of individuals potentially eligible; NES, number of eligible subjects; NE, number of events among the individuals potentially eligible; NEP, number of events prevented by BP-lowering drugs; NRE, number of residual events; YPLL, years of potential life lost; LYG, life-years gained; NNT, number needed to treat to gain a life-yearSensitivity analysis assessing the impact of the 2013 ESH/ESC Guidelines on costs, proportion of benefits and efficiency.